NCT04524234 (CARDYCOVID) is a clinical trial of Echocardiography in Covid19, sponsored by Sahlgrenska University Hospital.

Who is sponsoring NCT04524234?

NCT04524234 is sponsored by Sahlgrenska University Hospital.

What drugs are being tested in NCT04524234?

Interventions in NCT04524234: Echocardiography.

What condition does NCT04524234 study?

NCT04524234 studies Covid19, Left Ventricular Dysfunction, Right Ventricular Dysfunction, Pulmonary Hypertension.

Is NCT04524234 still recruiting?

NCT04524234 is currently completed. Last updated 24 December 2020.

Last reviewed 2020-12-24 · How we verify

NCT04524234: CARDYCOVID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cardiac Dysfunction in Critically Ill Patients With COVID-19

Completed Last updated 24 December 2020

What this trial tests

trial testing Echocardiography in Covid19 in 132 participants. Completed in 30 September 2020.

Timeline

20 April 2020

Primary endpoint
31 August 2020

30 September 2020

Quick facts

Lead sponsor	Sahlgrenska University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	132
Start date	20 April 2020
Primary completion	31 August 2020
Estimated completion	30 September 2020
Sites	5 locations across Sweden

Drugs / interventions tested

Echocardiography

Conditions studied

Covid19 — all drugs for Covid19 →
Left Ventricular Dysfunction — all drugs for Left Ventricular Dysfunction →
Right Ventricular Dysfunction — all drugs for Right Ventricular Dysfunction →
Pulmonary Hypertension — all drugs for Pulmonary Hypertension →

Sponsor

Sahlgrenska University Hospital

Who can join

Adults 18 to 99, any sex, with Covid19 or Left Ventricular Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac dysfunction has been reported to be common in patients infected with COVID-19. The aim of this study is to evaluate the clinical importance of cardiac dysfunction in critically ill patients infected with COVID-19.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Cardiac involvement in the long-term implications of COVID-19.
Satterfield BA, Bhatt DL, Gersh BJ. · · 2022 · cited 101× · PMID 34686843 · DOI 10.1038/s41569-021-00631-3
Cardiac dysfunction and mortality in critically ill patients with COVID-19: A Swedish multicentre observational study.
Holmqvist J, Beck-Friis J, Jensen C, Dalla K, et al · · 2022 · cited 7× · PMID 35122232 · DOI 10.1111/aas.14039
Cardiac Dysfunction in Critically Ill patients with COVID-19 – A Multicentre Observational Study
Holmqvist J, Beck-Friis J, Jensen C, Dalla K, et al · · 2021 · DOI 10.21203/rs.3.rs-138541/v1

Verify or expand the search:

Other trials of Echocardiography

Trials testing the same drug.

NCT06863402 — Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype · Phase 2 · recruiting
NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
NCT06434064 — Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advan · Phase 2 · recruiting
NCT06871410 — Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · Phase 1 · recruiting
NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Sahlgrenska University Hospital trials

Trials by the same sponsor.

NCT07491094 — Repeated Examinations for Typing Pulmonary Embolism · recruiting
NCT07524608 — Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Pa · not yet recruiting
NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
NCT06896578 — Latitude - Lateral Lymph Node Attitude Study · NA · not yet recruiting
NCT07035600 — Walking and Sitting Difficulties After Rectal Cancer Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04524234 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sahlgrenska University Hospital
Last refreshed: 24 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04524234.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing